tiprankstipranks
Advertisement
Advertisement

Keswick Family Trusts Reshape Stakes in Jardine Matheson

Story Highlights
  • Jardine Matheson reported off-market share dealings involving directors Ben and Adam Keswick.
  • A family trust sold 1.7 million shares as the Keswicks bought stock for children’s trusts.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Keswick Family Trusts Reshape Stakes in Jardine Matheson

Meet Samuel – Your Personal Investing Prophet

Jardine Matheson Holdings ( (GB:JAR) ) just unveiled an update.

Jardine Matheson has disclosed a series of share transactions involving directors Ben and Adam Keswick and a related family trust, in line with regulatory requirements for dealings by persons discharging managerial responsibilities. Butterfield Trust (Bermuda), acting as trustee of family trusts associated with the Keswick family, disposed of 1,697,368 Jardine Matheson ordinary shares on 30 March 2026 in an off-market transaction.

On the same date, directors Adam and Ben Keswick each acquired 250,000 Jardine Matheson ordinary shares in an off-market transaction, holding the stock as trustees for their children. The disclosures highlight ongoing Keswick family-related restructuring of holdings in the group, but do not indicate any change in board roles or immediate strategic shift for the conglomerate’s operations.

The most recent analyst rating on (GB:JAR) stock is a Buy with a $94.00 price target. To see the full list of analyst forecasts on Jardine Matheson Holdings stock, see the GB:JAR Stock Forecast page.

More about Jardine Matheson Holdings

Jardine Matheson Holdings is a diversified Asian-focused conglomerate with interests spanning retail, property, motors, hospitality, and financial services. Listed in London and Singapore with a Bermuda registration, the group manages a portfolio of regional market-leading businesses across Greater China and Southeast Asia.

Average Trading Volume: 807

Technical Sentiment Signal: Buy

Current Market Cap: $21.35B

For an in-depth examination of JAR stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1